🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 31773D101
- Market Cap
- Large Cap · $1 Billion
- IPO
- 3/19/2021 · $17.00/share
Business: Finch Therapeutics is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs.
Company Contact
- CEO
- Mark Smith
- CFO
-
Marc Blaustein
- Headquarters
- 200 Inner Belt Road, Suite 400, Somerville, MA 02143
- Phone
- 617-229-6499
- Investor Relations
- ir@finchtherapeutics.com